| Thursday, November 28th 2024 |
Is Palantir on the Precipice of a Sharp Fall? |
Palantir (NYSE:PLTR) has been among the biggest beneficiaries of this year's AI bull run and the more recent post-election rally. The stock started this year at just $16.58 and has since skyrocketed to over $60 per share. The last month has been particularly dramatic when PLTR started November a little over $40 before being pushed skyward following election news that was deemed positive and a stellar Q3 earnings report. Get the full details here |
Burst Content You May Have Missed
|
Will Trump's Energy Secretary Pick Drive Oklo Higher?
|
Oklo (NYSE: OKLO) shares surged over 18% Monday after President-elect Donald Trump named Liberty Energy CEO Chris Wright as his pick for Energy Secretary. For Oklo investors, the selection carries special significance – Wright currently serves on Oklo's board of directors, potentially giving the nuclear innovation company an influential ally in Washington just as it hits its stride with commercial deployments and new acquisitions. Get the full details here |
1 Organ Transplant Disruptor to Buy on the Dip |
TransMedics (NASDAQ:TMDX) is an innovative biotechnology company that may well have the potential to disrupt the $11 billion organ transplant industry. The company's unique organ care system technology protects and monitors donor organs before they are transplanted into patients, resulting in improved organ health and outcomes. Get the full details here |
Brilliant Billionaire Buys Under-the-Radar Wide Moat Stock |
In B2B sales and marketing, few companies have built as powerful a toolset as the one that caught Stan Druckenmiller's eye. With a unique moat in its vast proprietary database, accelerating AI-driven insights, and a growing foothold in emerging markets, this SaaS firm has become a must-have resource for enterprise sales teams. Get the full details here |
|
 |
|
| | Advertising Disclosure: This email may contain paid advertisements. Summa Money publishes 4 newsletters with various areas of focus. The Ivy is delivered 3x per week with a focus on investments that could generate passive income. The Burst is delivered 2x per week with a focus on growth stocks. The Spotlight is delivered 1x per week with a focus on high potential stocks and economic insights. The Daily is an occasional newsletter with a focus on the best investing stories and news from around the world. We hope you enjoy them all, but feel free to unsubscribe from the content you do not want to receive. If you do not wish to receive this email, then we apologize for the inconvenience. You can immediately discontinue receiving this email by clicking the unsubscribe link at the bottom of this email. If you have any questions, please send an email with your questions to support@summamoney.com. Nothing in this email should be considered personalized financial advice. We strongly urge you to read our full disclaimer here. If you can't see this message, view it in your browser. You are receiving this e-mail at edwardlorilla1986.paxforex@blogger.com as a part of your free subscription to the Burst Newsletter. To read our privacy policy follow this link. or To unsubscribe by mail, write us at: Summa Money | 2319 N Andrews Ave. Fort Lauderdale, FL 33311 Website: Summa Money Nothing in this email should be considered personalized financial advice. Staff members at Summa Money are not qualified to answer your investing-related questions as they are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Copyright 2024 Summa Money. All rights reserved. Advertise With Us |
|
|
In order to unsubscribe from this mailing list, please click
here 
No comments:
Post a Comment